Pyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBC
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Pain Phenotyping of Patients With Bone Cancer Pain
- Status
- UNKNOWN
- Phase
- N/A
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer
- Status
- COMPLETED
- Phase
- N/A
ModraDoc006/r in Patients With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Pharmacokinetics of ODM-209
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pyrotinib Combined With Docetaxel in the First-line Treatment of HER2-positive MBC
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Pyrotinib in Combination With Trastuzumab and Docetaxel in Patients With HER2 Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor
- Status
- COMPLETED
- Phase
- PHASE1
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- NA
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
- Status
- RECRUITING
- Phase
- PHASE2
Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE1
Vaccination With Flt3L, Radiation, and Poly-ICLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
BP-C1 Monotherapy in Patients With Metastatic Breast Cancer Cancer: Estimation of Optimal Duration of Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Study of Euthyroid Hypothyroxinemia in Metastatic Breast Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Sweden Cancerome Analysis Network - Breast Recurrence (SCAN-B-rec)
- Status
- RECRUITING
- Phase
- N/A
Efficacy and Safety of Trastuzumab Biosimilar (Herzuma®) Plus Treatment of Physician's Choice (TPC) in Patients With HER-2 Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1